Announcements

MDPI will be attending the 34th Annual Conference of the International Society for Environmental Epidemiology (ISEE 2022), held in Athens, Greece, from 18 to 21 September 2022. The main theme of the 2022 conference is “Strengthening the global role of environmental epidemiology”, stressing the need to study and understand local conditions in order to synthesize knowledge and make a difference for our planet. In the 2022 conference we will continue advancing our society’s aims in promoting epidemiological studies that link environmental exposures to human health.

During this conference, MDPI (at booth #22) will welcome researchers from different backgrounds to visit and share their latest inspirations with us.

The following MDPI journals will be represented:

• IJERPH (leading journal);
• Sustainability;
• Healthcare;
• Children;
• Cancers;
• Climate;
• Environments;
• Earth;
• Societies;
• Epidemiologia.

If you plan on attending this conference, feel free to stop by our booth: #22. Our delegates look forward to meeting you in person to answer any questions that you may have.

For more information about the conference, please see the following link: https://isee2022.org/.

1 . “Impact of the COVID-19 Pandemic on Cancer Diagnoses in General and Specialized Practices in Germany”
by Jacob, L.; Loosen, S. H.; Kalder, M.; Luedde, T.; Roderburg, C.; Kostev, K.
Cancers 2021, 13(3), 408; https://doi.org/10.3390/cancers13030408
Available online: https://www.mdpi.com/2072-6694/13/3/408

2. “A Narrative Review of the Role of Diet and Lifestyle Factors in the Development and Prevention of Endometrial Cancer”
by Yasin, H. K.; Taylor, A. H.; Ayakannu, T.
Cancers 2021, 13(9), 2149; https://doi.org/10.3390/cancers13092149
Available online: https://www.mdpi.com/2072-6694/13/9/2149

3. “Overview of Oral Potentially Malignant Disorders: From Risk Factors to Specific Therapies”
by Lorini, L.; Bescós Atín, C.; Thavaraj, S.; Müller-Richter, U.; Alberola Ferranti, M.; Pamias Romero, J.; Sáez Barba, M.; de Pablo García-Cuenca, A.; Braña García, I.; Bossi, P. et al.
Cancers 2021, 13(15), 3696; https://doi.org/10.3390/cancers13153696
Available online: https://www.mdpi.com/2072-6694/13/15/3696

4. “Fucoxanthin and Colorectal Cancer Prevention”
by Terasaki, M.; Kubota, A.; Kojima, H.; Maeda, H.; Miyashita, K.; Kawagoe, C.; Mutoh, M.; Tanaka, T.
Cancers 2021, 13(10), 2379; https://doi.org/10.3390/cancers13102379
Available online: https://www.mdpi.com/2072-6694/13/10/2379

5. “Lymphopenia as a Biological Predictor of Outcomes in COVID-19 Patients: A Nationwide Cohort Study”
by Lee, J.; Park, S.-S.; Kim, T. Y.; Lee, D.-G.; Kim, D.-W.
Cancers 2021, 13(3), 471; https://doi.org/10.3390/cancers13030471
Available online: https://www.mdpi.com/2072-6694/13/3/471

6. “Mycobiome and Cancer: What Is the Evidence?”
by Lee, J.; Park, S.-S.; Kim, T.Y.; Lee, D.-G.; Kim, D.-W.
Cancers 2021, 13(13), 3149; https://doi.org/10.3390/cancers13133149
Available online: https://www.mdpi.com/2072-6694/13/13/3149

7. “Comparison of Cancer Patients to Non-Cancer Patients among COVID-19 Inpatients at a National Level”
by Bernard, A.; Cottenet, J.; Bonniaud, P.; Piroth, L.; Arveux, P.; Tubert-Bitter, P.; Quantin, C.
Cancers 2021, 13(6), 1436; https://doi.org/10.3390/cancers13061436
Available online: https://www.mdpi.com/2072-6694/13/6/1436

8. “Towards Novel Non-Invasive Colorectal Cancer Screening Methods: A Comprehensive Review”
by Ferrari, A.; Neefs, I.; Hoeck, S.; Peeters, M.; Van Hal, G.
Cancers 2021, 13(8), 1820; https://doi.org/10.3390/cancers13081820
Available online: https://www.mdpi.com/2072-6694/13/8/1820

9. “Renal Cell Carcinoma Health Disparities in Stage and Mortality among American Indians/Alaska Natives and Hispanic Americans: Comparison of National Cancer Database and Arizona Cancer Registry Data”
by Valencia, C. I.; Asmar, S.; Hsu, C.-H.; Gachupin, F. C.; Wong, A. C.; Chipollini, J.; Lee, B. R.; Batai, K.
Cancers 2021, 13(5), 990; https://doi.org/10.3390/cancers13050990
Available online: https://www.mdpi.com/2072-6694/13/5/990

10. “Evaluation of Antibody Responses to COVID-19 Vaccines among Solid Tumor and Hematologic Patients”
by Valencia, C. I.; Asmar, S.; Hsu, C.-H.; Gachupin, F. C.; Wong, A. C.; Chipollini, J.; Lee, B. R.; Batai, K. et al.
Cancers 2021, 13(17), 4312; https://doi.org/10.3390/cancers13174312
Available online: https://www.mdpi.com/2072-6694/13/17/4312

1. “The Clinical Utility of Optical Genome Mapping for the Assessment of Genomic Aberrations in Acute Lymphoblastic Leukemia”
by Lühmann, J. L.; Stelter, M.; Wolter, M.; Kater, J.; Lentes, J.; Bergmann, A. K.; Schieck, M.; Göhring, G.; Möricke, A.; Cario, G. et al.
Cancers 2021, 13(17), 4388; https://doi.org/10.3390/cancers13174388
Available online: https://www.mdpi.com/2072-6694/13/17/4388

2. “The Microbiome in Childhood Acute Lymphoblastic Leukemia”
by Oldenburg, M.; Rüchel, N.; Janssen, S.; Borkhardt, A.; Gössling, K. L.
Cancers 2021, 13(19), 4947; https://doi.org/10.3390/cancers13194947
Available online: https://www.mdpi.com/2072-6694/13/19/4947

3. “Plasticity in Neuroblastoma Cell Identity Defines a Noradrenergic-to-Mesenchymal Transition (NMT)”
by Gautier, M.; Thirant, C.; Delattre, O.; Janoueix-Lerosey, I.
Cancers 2021, 13(12), 2904; https://doi.org/10.3390/cancers13122904
Available online: https://www.mdpi.com/2072-6694/13/12/2904
 
4. “Pediatric Mixed-Phenotype Acute Leukemia: What’s New?”
by Batra, S.; Ross, A. J.
Cancers 2021, 13(18), 4658; https://doi.org/10.3390/cancers13184658
Available online: https://www.mdpi.com/2072-6694/13/18/4658
 
5. “Preliminary Radiogenomic Evidence for the Prediction of Metastasis and Chemotherapy Response in Pediatric Patients with Osteosarcoma Using 18F-FDG PET/CT, EZRIN, and KI67”
by Kim, B.-C.; Kim, J.; Kim, K.; Byun, B. H.; Lim, I.; Kong, C.-B.; Song, W. S.; Koh, J.-S.; Woo, S.-K.
Cancers 2021, 13(11), 2671; https://doi.org/10.3390/cancers13112671
Available online: https://www.mdpi.com/2072-6694/13/11/2671
 
6. “Unbalance in Iron Metabolism in Childhood Leukemia Converges with Treatment Intensity: Biochemical and Clinical Analysis”
by Łęcka, M.; Słomka, A.; Albrecht, K.; Żekanowska, E.; Romiszewski, M.; Styczyński, J.
Cancers 2021, 13(12), 3029; https://doi.org/10.3390/cancers13123029
Available online: https://www.mdpi.com/2072-6694/13/12/3029
 
7. “Natural History of Untreated Retinoblastoma”
by Zhao, J.; Feng, Z.; Gallie, B. L.
Cancers 2021, 13(15), 3646; https://doi.org/10.3390/cancers13153646
Available online: https://www.mdpi.com/2072-6694/13/15/3646
 
8. “Advances in the First Line Treatment of Pediatric Acute Myeloid Leukemia in the Polish Pediatric Leukemia and Lymphoma Study Group from 1983 to 2019”
by Czogała, M.; Balwierz, W.; Pawińska-Wąsikowska, K.; Książek, T.; Bukowska-Strakova, K.; Czogała, W.; Sikorska-Fic, B.; Matysiak, M.; Skalska-Sadowska, J.; Wachowiak, J. et al.
Cancers 2021, 13(18), 4536; https://doi.org/10.3390/cancers13184536
Available online: https://www.mdpi.com/2072-6694/13/18/4536
 
9. “Transcriptional and Mutational Profiling of B-Other Acute Lymphoblastic Leukemia for Improved Diagnostics”
by Chouvarine, P.; Antić, Ž.; Lentes, J.; Schröder, C.; Alten, J.; Brüggemann, M.; Carrillo-de Santa Pau, E.; Illig, T.; Laguna, T.; Schewe, D. et al.
Cancers 2021, 13(22), 5653; https://doi.org/10.3390/cancers13225653
Available online: https://www.mdpi.com/2072-6694/13/22/5653
 
10. “Overcoming PD-1 Inhibitor Resistance with a Monoclonal Antibody to Secreted Frizzled-Related Protein 2 in Metastatic Osteosarcoma”
by Nasarre, P.; Garcia, D. I.; Siegel, J. B.; Bonilla, I. V.; Mukherjee, R.; Hilliard, E.; Chakraborty, P.; Nasarre, C.; Yustein, J. T.; Lang, M. et al.
Cancers 2021, 13(11), 2696; https://doi.org/10.3390/cancers13112696
Available online: https://www.mdpi.com/2072-6694/13/11/2696

MDPI will be attending the 2022 CAGPO ACMOO Annual Conference, hosted by the 2022 CAGPO Annual Conference Committee, which will be held from 15 to 18 September 2022 in Toronto, Canada.

The CAGPO mission statement is to unify general practitioners in oncology, promote communication amongst general practitioners in oncology in tertiary care and primary care settings, act and speak as the recognized authority on behalf of and for the benefit of general practitioners in oncology and their interests, and promote the role of general practitioners in oncology within cancer centers and within the primary care setting. The conference is to address the learning needs of general practitioners in oncology (GPOs) and oncology-allied health attendees. During this meeting, we will address recent advancements in the standards of oncology care. Our speakers include GPOs, medical and radiation oncologists, as well as speakers from the disciplines of family medicine and clinical trials.

The following MDPI journals will be represented:

• Current Oncology (leading);
• Cancers;
• Medical Sciences;
• Pharmacy;
• Journal of Clinical Medicine;
• Cells;
• Onco.

If you are attending this conference, please feel free to start an on-site conversation with us. Our delegates look forward to meeting you in person and answering any questions that you may have.

For more information about the conference, please visit the following link: http://cagpo-annual-conference.ca, or contact the Current Oncology Editorial Office at curroncol@mdpi.com.

MDPI will be attending ASHG 2022, held in Los Angeles, USA, from 25 to 29 October 2022.

The following MDPI journals will be represented:

• Genes;
• JPM;
• Biomedicines;
• Biomolecules;
• Cardiogenetics;
• Cancers;
• Brain Science;
• Symmetry;
• Diagnostics;
• Metabolites;
• Cells;
• Biology;
• Humans;
• DNA.

If you plan on attending this conference, feel free to stop by our booth: #1844. Our delegates look forward to meeting you in person to answer any questions you may have.

For more information about the conference, please see the following link:

https://www.ashg.org/meetings/2022-annual-meeting/.

1. “Global Burden, Risk Factors, and Trends of Esophageal Cancer: An Analysis of Cancer Registries from 48 Countries”
by Huang, J.; Koulaouzidis, A.; Marlicz, W.; Lok, V.; Chu, C.; Ngai, C. H.; Zhang, L.; Chen, P.; Wang, S.; Yuan, J.; et al.
Cancers 2021, 13(1), 141; https://doi.org/10.3390/cancers13010141
Available online: https://www.mdpi.com/2072-6694/13/1/141

2. “A Review of Circulating Tumour Cell Enrichment Technologies”
by Rushton, A. J.; Nteliopoulos, G.; Shaw, J. A.; Coombes, R. C.
Cancers 2021, 13(5), 970; https://doi.org/10.3390/cancers13050970
Available online: https://www.mdpi.com/2072-6694/13/5/970

3. “Cancer-Associated Fibroblasts as Players in Cancer Development and Progression and Their Role in Targeted Radionuclide Imaging and Therapy”
by Koustoulidou, S.; Hoorens, M. W. H.; Dalm, S. U.; Mahajan, S.; Debets, R.; Seimbille, Y.; de Jong, M.
Cancers 2021, 13(5), 1100; https://doi.org/10.3390/cancers13051100
Available online: https://www.mdpi.com/2072-6694/13/5/1100

4. “Home-Based Aerobic and Resistance Exercise Interventions in Cancer Patients and Survivors: A Systematic Review”
by Batalik, L.; Winnige, P.; Dosbaba, F.; Vlazna, D.; Janikova, A.
Cancers 2021, 13(8), 1915; https://doi.org/10.3390/cancers13081915
Available online: https://www.mdpi.com/2072-6694/13/8/1915

5. “Exploring the Potential Role of the Gut Microbiome in Chemotherapy-Induced Neurocognitive Disorders and Cardiovascular Toxicity”
by Ciernikova, S.; Mego, M.; Chovanec, M.
Cancers 2021, 13(4), 782; https://doi.org/10.3390/cancers13040782
Available online: https://www.mdpi.com/2072-6694/13/4/782

6. “Fatigue in Cancer Patients in Palliative Care—A Review on Pharmacological Interventions”
by Klasson, C.; Helde Frankling, M.; Lundh Hagelin, C.; Björkhem-Bergman, L.
Cancers 2021, 13(5), 985; https://doi.org/10.3390/cancers13050985
Available online: https://www.mdpi.com/2072-6694/13/5/985

7. “Angiogenesis Inhibitors for Colorectal Cancer. A Review of the Clinical Data”
by Hansen, T. F.; Qvortrup, C.; Pfeiffer, P.
Cancers 2021, 13(5), 1031; https://doi.org/10.3390/cancers13051031
Available online: https://www.mdpi.com/2072-6694/13/5/1031

8. “Adolescent and Young Adult (AYA) Cancer Survivorship Practices: An Overview”
by Janssen, S. H. M.; van der Graaf, W. T. A.; van der Meer, D. J.; Manten-Horst, E.; Husson, O.
Cancers 2021, 13(19), 4847; https://doi.org/10.3390/cancers13194847
Available online: https://www.mdpi.com/2072-6694/13/19/4847

9. “Comparative Evaluation of Novel ¹⁷⁷Lu-Labeled PNA Probes for Affibody-Mediated PNA-Based Pretargeting”
by Tano, H.; Oroujeni, M.; Vorobyeva, A.; Westerlund, K.; Liu, Y.; Xu, T.; Vasconcelos, D.; Orlova, A.; Karlström, A. E.; Tolmachev, V.
Cancers 2021, 13(3), 500; https://doi.org/10.3390/cancers13030500
Available online: https://www.mdpi.com/2072-6694/13/3/500

10. “Emerging Pharmacological and Non-Pharmacological Therapeutics for Prevention and Treatment of Chemotherapy-Induced Peripheral Neuropathy”
by Li, Y.; Lustberg, M. B.; Hu, S.
Cancers 2021, 13(4), 766; https://doi.org/10.3390/cancers13040766
Available online: https://www.mdpi.com/2072-6694/13/4/766

1. “Trends in Research on Exosomes in Cancer Progression and Anticancer Therapy”
by Sinha, D.; Roy, S.; Saha, P.; Chatterjee, N.; Bishayee, A.
Cancers 2021, 13(2), 326; https://doi.org/10.3390/cancers13020326
Available online: https://www.mdpi.com/2072-6694/13/2/326

2. “Mechanisms of Resistance to KRASG12C Inhibitors”
by Dunnett-Kane, V.; Nicola, P.; Blackhall, F.; Lindsay, C.
Cancers 2021, 13(1), 151; https://doi.org/10.3390/cancers13010151
Available online: https://www.mdpi.com/2072-6694/13/1/151

3. “Tumor Hypoxia as a Barrier in Cancer Therapy: Why Levels Matter”
by Hompland, T.; Fjeldbo, C. S.; Lyng, H.
Cancers 2021, 13(3), 499; https://doi.org/10.3390/cancers13030499
Available online: https://www.mdpi.com/2072-6694/13/3/499

4. “Circular RNAs: Emerging Regulators of the Major Signaling Pathways Involved in Cancer Progression”
by Papatsirou, M.; Artemaki, P. I.; Karousi, P.; Scorilas, A.; Kontos, C. K.
Cancers 2021, 13(11), 2744; https://doi.org/10.3390/cancers13112744
Available online: https://www.mdpi.com/2072-6694/13/11/2744

5. “Targeting CDK9 for Anti-Cancer Therapeutics”
by Mandal, R.; Becker, S.; Strebhardt, K.
Cancers 2021, 13(9), 2181; https://doi.org/10.3390/cancers13092181
Available online: https://www.mdpi.com/2072-6694/13/9/2181

6. “EGFR in Cancer: Signaling Mechanisms, Drugs, and Acquired Resistance”
by Uribe, M. L.; Marrocco, I.; Yarden, Y.
Cancers 2021, 13(11), 2748; https://doi.org/10.3390/cancers13112748
Available online: https://www.mdpi.com/2072-6694/13/11/2748

7. “The Role and Therapeutic Targeting of JAK/STAT Signaling in Glioblastoma”
by Ou A.; Ott M.; Fang D.; Heimberger A. B.
Cancers 2021, 13(3), 437; https://doi.org/10.3390/cancers13030437
Available online: https://www.mdpi.com/2072-6694/13/3/437

8. “Cancer-Associated Fibroblasts as a Common Orchestrator of Therapy Resistance in Lung and Pancreatic Cancer”
by Domen, A.; Quatannens, D.; Zanivan, S.; Deben, C.; Van Audenaerde, J.; Smits, E.; Wouters, A.; Lardon, F.; Roeyen, G.; Verhoeven, Y.; Janssens, A.; Vandamme, T.; van Dam, P.; Peeters, M.; Prenen, H. 
Cancers 2021, 13(5), 987; https://doi.org/10.3390/cancers13050987
Available online: https://www.mdpi.com/2072-6694/13/5/987

9. “Drug Resistance in Osteosarcoma: Emerging Biomarkers, Therapeutic Targets and Treatment Strategies”
by Hattinger, C. M.; Patrizio, M. P.; Fantoni, L.; Casotti, C.; Riganti, C.; Serra, M.
Cancers 2021, 13(12), 2878; https://doi.org/10.3390/cancers13122878
Available online: https://www.mdpi.com/2072-6694/13/12/2878

10. “Hypoxia-Induced Cancer Cell Responses Driving Radioresistance of Hypoxic Tumors: Approaches to Targeting and Radiosensitizing”
by Kabakov, A. E.; Yakimova, A. O. 
Cancers 2021, 13(5), 1102; https://doi.org/10.3390/cancers13051102
Available online: https://www.mdpi.com/2072-6694/13/5/1102

Cancers (ISSN: 2072-6694) will be attending ESMO 2022, held in Paris, France, from 9 to 13 September 2022. The European Society for Medical Oncology (ESMO) conference is the most important annual event with the greatest impact on cancer research, open to scholars and specialists from academia and the medical profession. During this conference, MDPI (at booth #P231) will welcome researchers from different backgrounds to visit and share their latest inspirations with us.

The following MDPI journals will be represented:

• Cancers (leading journal);
• Cells;
• Current Oncology;
• Biomedicines;
• Diagnostics;
• Future Pharmacology;
• IJMS;
• Onco;
• Pharmaceutics.

If you plan on attending this conference, feel free to stop by our booth #P231. Our delegates look forward to meeting you in person to answer any questions you may have.

For more information about the conference, please see the following link: https://www.esmo.org/.

1. “Surgical Management of the Axilla in Clinically Node-Positive Breast Cancer Patients Converting to Clinical Node Negativity through Neoadjuvant Chemotherapy: Current Status, Knowledge Gaps, and Rationale for the EUBREAST-03 AXSANA Study”
by Banys-Paluchowski, M.; Gasparri, M. L.; de Boniface, J.; Gentilini, O.; Stickeler, E.; Hartmann, S.; Thill, M.; Rubio, I. T.; Di Micco, R.; Bonci, E.-A.; et al.
Cancers 2021, 13(7), 1565; https://doi.org/10.3390/Cancers13071565
Available online: https://www.mdpi.com/2072-6694/13/7/1565 

2. “Adoptive Cell Therapy in Hepatocellular Carcinoma: Biological Rationale and First Results in Early Phase Clinical Trials”
by Rochigneux, P.; Chanez, B.; De Rauglaudre, B.; Mitry, E.; Chabannon, C.; Gilabert, M.
Cancers 2021, 13(2), 271; https://doi.org/10.3390/Cancers13020271
Available online: https://www.mdpi.com/2072-6694/13/2/271

3. “Targeting the Fibroblast Growth Factor Receptor (FGFR) in Advanced Cholangiocarcinoma: Clinical Trial Progress and Future Considerations”
by Lee, P. C.; Hendifar, A.; Osipov, A.; Cho, M.; Li, D.; Gong, J.
Cancers 2021, 13(7), 1706; https://doi.org/10.3390/Cancers13071706
Available online: https://www.mdpi.com/2072-6694/13/7/1706

4. “The Role of Cancer Stem Cells in Colorectal Cancer: From the Basics to Novel Clinical Trials”
by Hervieu, C.; Christou, N.; Battu, S.; Mathonnet, M.
Cancers 2021, 13(5), 1092; https://doi.org/10.3390/Cancers13051092
Available online: https://www.mdpi.com/2072-6694/13/5/1092

5. “N-3 Long-Chain Polyunsaturated Fatty Acids, Eicosapentaenoic and Docosahexaenoic Acid, and the Role of Supplementation during Cancer Treatment: A Scoping Review of Current Clinical Evidence”
by Newell, M.; Mazurak, V.; Postovit, L. M.; Field, C. J.
Cancers 2021, 13(6), 1206; https://doi.org/10.3390/Cancers13061206
Available online: https://www.mdpi.com/2072-6694/13/6/1206

6. “Unique Features of Hepatitis B Virus-Related Hepatocellular Carcinoma in Pathogenesis and Clinical Significance”
by Wang, S.-H.; Yeh, S.-H.; Chen, P.-J.
Cancers 2021, 13(10), 2454; https://doi.org/10.3390/Cancers13102454
Available online: https://www.mdpi.com/2072-6694/13/10/2454

7. “The Effects of High-Intensity Interval Training vs. Moderate-Intensity Continuous Training on Inflammatory Markers, Body Composition, and Physical Fitness in Overweight/Obese Survivors of Breast Cancer: A Randomized Controlled Clinical Trial”
by Hooshmand Moghadam, B.; Golestani, F.; Bagheri, R.; Cheraghloo, N.; Eskandari, M.; Wong, A.; Nordvall, M.; Suzuki, K.; Pournemati, P.
Cancers 2021, 13(17), 4386; https://doi.org/10.3390/Cancers13174386
Available online: https://www.mdpi.com/2072-6694/13/17/4386

8. “Interstitial Photodynamic Therapy for Glioblastomas: A Standardized Procedure for Clinical Use”
by Leroy, H.-A.; Baert, G.; Guerin, L.; Delhem, N.; Mordon, S.; Reyns, N.
Cancers 2021, 13(22), 5754; https://doi.org/10.3390/Cancers13225754
Available online: https://www.mdpi.com/2072-6694/13/22/5754

9. “Targeted Treatment of Head and Neck (Pre)Cancer: Preclinical Target Identification and Development of Novel Therapeutic Applications”
by van Harten, A. M.; Brakenhoff, R. H.
Cancers 2021, 13(11), 2774; https://doi.org/10.3390/Cancers13112774
Available online: https://www.mdpi.com/2072-6694/13/11/2774

10. “Could Photodynamic Therapy Be a Promising Therapeutic Modality in Hepatocellular Carcinoma Patients? A Critical Review of Experimental and Clinical Studies”
by Kumar, A.; Moralès, O.; Mordon, S.; Delhem, N.
Cancers 2021, 13(20), 5176; https://doi.org/10.3390/Cancers13205176
Available online: https://www.mdpi.com/2072-6694/13/20/5176

1. “Liquid Biopsy in Pancreatic Cancer: Are We Ready to Apply It in the Clinical Practice?”
by Victoria Heredia-Soto; Nuria Rodríguez-Salas; Jaime Feliu
Cancers 2021, 13(8), 1986; https://doi.org/10.3390/cancers13081986
Available online: https://www.mdpi.com/2072-6694/13/8/1986

2. “New Molecular Mechanisms and Clinical Impact of circRNAs in Human Cancer”
by Giulia Fontemaggi; Chiara Turco; Gabriella Esposito; Silvia Di Agostino
Cancers 2021, 13(13), 3154; https://doi.org/10.3390/cancers13133154
Available online: https://www.mdpi.com/2072-6694/13/13/3154

3. “Ki-67 as a Prognostic Biomarker in Invasive Breast Cancer”
by Matthew G. Davey; Sean O. Hynes; Michael J. Kerin; Nicola Miller; Aoife J. Lowery
Cancers 2021, 13(17), 4455; https://doi.org/10.3390/cancers13174455
Available online: https://www.mdpi.com/2072-6694/13/17/4455

4. “Functional Interaction among lncRNA HOTAIR and MicroRNAs in Cancer and Other Human Diseases”
by Monica Cantile; Maurizio Di Bonito; Maura Tracey De Bellis; Gerardo Botti
Cancers 2021, 13(3), 570; https://doi.org/10.3390/cancers13030570
Available online: https://www.mdpi.com/2072-6694/13/3/570

5. “Resistance to Molecularly Targeted Therapies in Melanoma”
by Meet Patel; Adam Eckburg; Shahina Gantiwala; Zachary Hart; Joshua Dein; Katie Lam; Neelu Puri
Cancers 2021, 13(5), 1115; https://doi.org/10.3390/cancers13051115
Available online: https://www.mdpi.com/2072-6694/13/5/1115

6. “Biomarkers of Oncogenesis, Adipose Tissue Dysfunction and Systemic Inflammation for the Detection of Hepatocellular Carcinoma in Patients with Nonalcoholic Fatty Liver Disease”
by Gian Paolo Caviglia; Angelo Armandi; Chiara Rosso; Silvia Gaia; Serena Aneli; Emanuela Rolle; Maria Lorena Abate; Antonella Olivero; Aurora Nicolosi; Marta Guariglia; Davide Giuseppe Ribaldone; Patrizia Carucci; Giorgio Maria Saracco; Elisabetta Bugianesi
Cancers 2021, 13(10), 2305; https://doi.org/10.3390/cancers13102305
Available online: https://www.mdpi.com/2072-6694/13/10/2305

7. “Detection of Microsatellite Instability: State of the Art and Future Applications in Circulating Tumour DNA (ctDNA)”
by Pauline Gilson; Jean-Louis Merlin; Alexandre Harlé
Cancers 2021, 13(7), 1491; https://doi.org/10.3390/cancers13071491
Available online: https://www.mdpi.com/2072-6694/13/7/1491

8. “Urine as a Source of Liquid Biopsy for Cancer”
by Masanori Oshi; Vijayashree Murthy; Hideo Takahashi; Michelle Huyser; Maiko Okano; Yoshihisa Tokumaru; Omar M. Rashid; Ryusei Matsuyama; Itaru Endo; Kazuaki Takabe
Cancers 2021, 13(11), 2652; https://doi.org/10.3390/cancers13112652
Available online: https://www.mdpi.com/2072-6694/13/11/2652

9. “Non-Invasive Biomarkers for Earlier Detection of Pancreatic Cancer—A Comprehensive Review”
by Greta Brezgyte; Vinay Shah; Daria Jach; Tatjana Crnogorac-Jurcevic
Cancers 2021, 13(11), 2722; https://doi.org/10.3390/cancers13112722
Available online: https://www.mdpi.com/2072-6694/13/11/2722

10. “Cancer Epigenetic Biomarkers in Liquid Biopsy for High Incidence Malignancies”
by Cora Palanca-Ballester; Aitor Rodriguez-Casanova; Susana Torres; Silvia Calabuig-Fariñas; Francisco Exposito; Diego Serrano; Esther Redin; Karmele Valencia; Eloisa Jantus-Lewintre; Angel Diaz-Lagares; Luis Montuenga; Juan Sandoval; Alfonso Calvo
Cancers 2021, 13(12), 3016; https://doi.org/10.3390/cancers13123016
Available online: https://www.mdpi.com/2072-6694/13/12/3016